Mixed connective tissue disease (MCTD) is a rare autoimmune disorder with features of lupus, scleroderma, rheumatoid arthritis, and polymyositis. It is characterized by high levels of antibodies against ribonucleic proteins. Diagnostic criteria require at least 3 of 5 clinical features plus positive serology. Over time, many patients evolve features meeting criteria for other connective tissue diseases. Common clinical manifestations include Raynaud's phenomenon, arthritis, swollen hands, and lung and heart involvement. Prognosis depends on degree of organ involvement, with 5-year cumulative risks including pulmonary dysfunction in 66% and pericardial disease in 30% of patients.